| scholarly article | Q13442814 |
| P50 | author | Wei-Jia Kong | Q90134672 |
| P2093 | author name string | Yan Wang | |
| Jian-Dong Jiang | |||
| Can Wang | |||
| Ai-Ping Wang | |||
| Shu-Rong Ma | |||
| Yan-Bin Wu | |||
| Zeng-Yan Zuo | |||
| P2860 | cites work | Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis | Q26771826 |
| Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats. | Q64964716 | ||
| [Advance on study in anti-tumor mechamism of bererine (Ber)] | Q80679842 | ||
| Berberine activates thermogenesis in white and brown adipose tissue | Q86052055 | ||
| Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results | Q86551089 | ||
| Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats | Q91107064 | ||
| Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease | Q27301440 | ||
| Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice | Q28476820 | ||
| Adipocytes as regulators of energy balance and glucose homeostasis | Q29619448 | ||
| The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop | Q34440854 | ||
| Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice | Q34603941 | ||
| Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension | Q35512345 | ||
| Berberine Suppresses Adipocyte Differentiation via Decreasing CREB Transcriptional Activity | Q35558140 | ||
| Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice | Q36592306 | ||
| Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression | Q37716533 | ||
| Learning from berberine: Treating chronic diseases through multiple targets | Q38156718 | ||
| Galectin-3: an emerging all-out player in metabolic disorders and their complications | Q38258947 | ||
| Free fatty acids and IL-6 induce adipocyte galectin-3 which is increased in white and brown adipose tissues of obese mice | Q38305642 | ||
| Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function | Q38317758 | ||
| Galectin-3 inhibition prevents adipose tissue remodelling in obesity. | Q38382993 | ||
| Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway | Q38935541 | ||
| Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation | Q39858876 | ||
| Nonivamide enhances miRNA let-7d expression and decreases adipogenesis PPARγ expression in 3T3-L1 cells | Q40258732 | ||
| Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity. | Q40560953 | ||
| Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets | Q40944709 | ||
| Obesity and CardiovascularDiseases | Q41992568 | ||
| Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor | Q42467384 | ||
| A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain | Q42664377 | ||
| Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway | Q42798170 | ||
| Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. | Q42805774 | ||
| Functional study of the upregulation of miRNA-27a and miRNA-27b in 3T3-L1 cells in response to berberine | Q42808473 | ||
| Berberine inhibits adipogenesis in high-fat diet-induced obesity mice | Q42832699 | ||
| Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity. | Q42834230 | ||
| Protective effect of berberine on renal fibrosis caused by diabetic nephropathy | Q42835125 | ||
| Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. | Q43786750 | ||
| Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. | Q45984213 | ||
| Effects of berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 pre-adipocytes | Q46123793 | ||
| Effect of Weight Gain and Weight Loss on In Vivo Colonocyte Proliferation Rate in People with Obesity | Q46212076 | ||
| Relationship of galectin-3 with obesity, IL-6, and CRP in women | Q46298007 | ||
| Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). | Q47329197 | ||
| Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity. | Q47649685 | ||
| Galectin-3 levels relate in children to total body fat, abdominal fat, body fat distribution, and cardiac size | Q48043409 | ||
| Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. | Q48159180 | ||
| Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF in colons | Q50165602 | ||
| Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. | Q53576992 | ||
| Gastrodin Protects against Ethanol-Induced Liver Injury and Apoptosis in HepG2 Cells and Animal Models of Alcoholic Liver Disease. | Q54224802 | ||
| Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice. | Q54977524 | ||
| Obesity and nonalcoholic fatty liver disease: current perspectives | Q57069715 | ||
| Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways | Q58608459 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | adipocyte | Q357519 |
| P304 | page(s) | 13415 | |
| P577 | publication date | 2019-09-16 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3 | |
| P478 | volume | 9 |
Search more.